1. Photodynamic therapy with verteporfin for retinal angiomatous proliferation.
- Author
-
Francesco Boscia, Maurizio Parodi, Claudio Furino, Michele Reibaldi, and Carlo Sborgia
- Abstract
Abstract
Purpose The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV). [ABSTRACT FROM AUTHOR]- Published
- 2006
2. Transscleral Fixation of Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture: A Pilot Study.
- Author
-
Tomasz, Chorągiewicz, Katarzyna, Nowomiejska, Dariusz, Haszcz, Dominika, Nowakowska, Teresio, Avitabile, Michele, Reibaldi, Jünemann, Anselm Gerhard Maria, Mario Damiano, Toro, and Robert, Rejdak
- Subjects
APHAKIA ,POSTOPERATIVE period ,EYE ,PILOT projects ,VISUAL acuity - Abstract
Introduction: To assess long-term outcomes of implantation of black diaphragm intraocular lens (BD IOL) in post-traumatic aniridia and aphakia due to eye rupture. Methods: This is a retrospective consecutive case series of 14 eyes with post-traumatic complete aniridia and aphakia treated with scleral fixation BD IOL. Measurements included ophthalmological comorbidities, best corrected visual acuity (BCVA), complications, and postoperative interventions. The average postoperative follow-up period was 36 months. Results: BCVA improved in 6 cases, was stable in 6 cases and worsened in 2 cases. The lens was well centered in 13 cases. Glaucoma was diagnosed in six cases developed, and three of them required Ahmed valve implantation. One lens developed opacity. The cornea was decompensated in 6 cases, while two of them required penetrating keratoplasty. Conclusion: Implantation of BD IOL in eyes with severely traumatized eyes enables reconstruction of the anterior segment and some functional restoration, although many complications may arise during the longitudinal follow-up. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Intravitreal triamcinolone for macular edema in Lyme disease.
- Author
-
Michele Reibaldi, Salvatore Faro, Lorenzo Motta, and Antonio Longo
- Subjects
RELAPSING fever ,RETINOIDS ,LYME disease ,VISUAL acuity - Abstract
Abstract Background  To describe the outcome in a patient with macular edema caused by Lyme disease treated with injection of 4 mg intravitreal triamcinolone. Methods  The patient, 2 years after systemic Lyme disease treated with doxycycline for 4 weeks, developed macular edema with serous retinal detachment in one eye (visual acuity: 0.6). After unsuccessful therapy with intravenous ceftriaxone, indomethacin and acetazolamide, 4 mg intravitreal triamcinolone (IVTA) was injected via the pars plana. Results  Visual acuity improved to 1.0 and macular thickness recovered over 1 month. No changes were found in intraocular pressure. No recurrence of macular edema was seen after 2 years. Conclusions  IVTA can restore visual acuity and reduce macular thickness in macular edema caused by Lyme disease. However, since borreliosis is a systemic disease, previous systemic antibiotic treatment is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF